The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Treatment With Tissue Plasminogen Activator and Inpatient Mortality Rates for Patients With Ischemic Stroke Treated in Community Hospitals
Open accessAbstract
Background and Purpose — Most analyses of intravenous tissue plasminogen activator (IV tPA) use for acute stroke in routine practice have been limited by sample size and generally restricted to patients treated in large academic medical facilities. In the present study, we sought to estimate among community hospitals the use of IV tPA and to identify factors associated with the use of IV tPA and inpatient mortality. Methods — We evaluated a retrospective cohort of 23 058 patients with ischemic stroke from 137 community hospitals. Results — Three hundred sixty-two (1.6%) patients were treated with IV tPA, and 9.9% of those patients died during the hospitalization period. In 35.0% of the hospitals, no patients were treated with IV tPA, whereas 14.6% of hospitals treated ≈3.0% with IV tPA. After control for multiple factors, younger patients, more severely ill patients (OR 2.02, 95% CI 1.36 to 3.01), and patients treated in rural hospitals (OR 1.80, 95% CI 0.99 to 3.26) were more likely to receive IV tPA, whereas black patients were less likely (OR 0.54, 95% CI 0.31 to 0.95). There also was a trend showing that women were less likely to receive IV tPA (OR 0.84, 95% CI 0.69 to 1.03). Factors associated with an increased odds of inpatient mortality included receipt of IV tPA among men (OR 2.81, 95% CI 1.72 to 4.58) and increased age. Black patients were 27% less likely to die during hospitalization (95% CI 0.60 to 0.90). Conclusions — In this large, retrospective evaluation of community hospital practice, the use IV tPA and inpatient mortality rates among IV tPA–treated patients were consistent with those of other studies. The likelihood of receiving IV tPA varies by race, age, disease severity, and possibly gender. These factors may influence mortality rates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Clark, W. M., Wissman, S., Albers, G. W., Jhamandas, J. H., Madden, K. P., Hamilton, S., & for the ATLANTIS Study Investigators (1999) · JAMA · doi:10.1001/jama.282.21.2019 · Cited by 1,186
Albers, G. W., Bates, V. E., Clark, W. M., Bell, R., Verro, P., & Hamilton, S. A. (2000) · JAMA · doi:10.1001/jama.283.9.1145 · Cited by 700
Use of Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: The Cleveland Area Experience
Katzan, I. L., Furlan, A. J., Lloyd, L. E., Frank, J. I., Harper, D. L., Hinchey, J. A., Hammel, J. P., Qu, A., & Sila, C. A. (2000) · JAMA · doi:10.1001/jama.283.9.1151 · Cited by 648
Effects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year
Kwiatkowski, T. G., Libman, R. B., Frankel, M., Tilley, B. C., Morgenstern, L. B., Lu, M., Broderick, J. P., Lewandowski, C. A., Marler, J. R., Levine, S. R., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906103402302 · Cited by 647
Generalized Efficacy of t-PA for Acute Stroke: Subgroup Analysis of the NINDS t-PA Stroke Trial
The NINDS t-PA Stroke Study Group (1997) · Stroke · doi:10.1161/01.str.28.11.2119 · Cited by 559
Chiu, D., Krieger, D., Villar-Cordova, C., Kasner, S. E., Morgenstern, L. B., Bratina, P. L., Yatsu, F. M., & Grotta, J. C. (1998) · Stroke · doi:10.1161/01.str.29.1.18 · Cited by 406
Patients’ Awareness of Stroke Signs, Symptoms, and Risk Factors
Kothari, R., Sauerbeck, L., Jauch, E., Broderick, J., Brott, T., Khoury, J., & Liu, T. (1997) · Stroke · doi:10.1161/01.str.28.10.1871 · Cited by 362
Maynard, C. C. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.5.972 · Cited by 330
Cited by
Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes
Reeves, M. J., Bushnell, C. D., Howard, G., Gargano, J. W., Duncan, P. W., Lynch, G., Khatiwoda, A., & Lisabeth, L. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70193-5 · Cited by 1,362
Repairing the human brain after stroke: I. Mechanisms of spontaneous recovery
Cramer, S. C. (2008) · Annals of Neurology · doi:10.1002/ana.21393 · Cited by 875
Self-citationKurth, T., Walker, A. M., Glynn, R. J., Chan, K. A., Gaziano, J. M., Berger, K., & Robins, J. M. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj047 · Cited by 730
Hill, M. D. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.1041561 · Cited by 452
Stroke Epidemiology: Advancing Our Understanding of Disease Mechanism and Therapy
Ovbiagele, B., & Nguyen-Huynh, M. N. (2011) · Neurotherapeutics · doi:10.1007/s13311-011-0053-1 · Cited by 432
The Paul Coverdell Prototype Registries Writing Group* (2005) · Stroke · doi:10.1161/01.str.0000165902.18021.5b · Cited by 407
Heuschmann, P. U. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.16.1761 · Cited by 403
Schwamm, L. H., Pancioli, A., Acker, J. E., Goldstein, L. B., Zorowitz, R. D., Shephard, T. J., Moyer, P., Gorman, M., Johnston, S. C., Duncan, P. W., et al. (2005) · Circulation · doi:10.1161/01.cir.0000154252.62394.1e · Cited by 395
Stramba-Badiale, M., Fox, K. M., Priori, S. G., Collins, P., Daly, C., Graham, I., Jonsson, B., Schenck-Gustafsson, K., & Tendera, M. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi819 · Cited by 392
Task Force Members, Schwamm, L. H., Pancioli, A., Acker, J. E., Goldstein, L. B., Zorowitz, R. D., Shephard, T. J., Moyer, P., Gorman, M., Johnston, S. C., et al. (2005) · Stroke · doi:10.1161/01.str.0000158165.42884.4f · Cited by 313
Iraci, N., Leonardi, T., Gessler, F., Vega, B., & Pluchino, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020171 · Cited by 301
Race/Ethnicity, Quality of Care, and Outcomes in Ischemic Stroke
Schwamm, L. H., Reeves, M. J., Pan, W., Smith, E. E., Frankel, M. R., Olson, D., Zhao, X., Peterson, E., & Fonarow, G. C. (2010) · Circulation · doi:10.1161/circulationaha.109.881490 · Cited by 292
Utilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
Katzan, I. L., Hammer, M. D., Hixson, E. D., Furlan, A. J., Abou-Chebl, A., & Nadzam, D. M. (2004) · Archives of Neurology · doi:10.1001/archneur.61.3.346 · Cited by 289
Bandera, E., Botteri, M., Minelli, C., Sutton, A., Abrams, K. R., & Latronico, N. (2006) · Stroke · doi:10.1161/01.str.0000217418.29609.22 · Cited by 274
Prioritizing interventions to improve rates of thrombolysis for ischemic stroke
California Acute Stroke Pilot Registry (CASPR) Investigators (2005) · Neurology · doi:10.1212/01.wnl.0000151850.39648.51 · Cited by 274
Ethnic Disparities in Stroke: Epidemiology, Acute Care, and Postacute Outcomes
Stansbury, J. P., Jia, H., Williams, L. S., Vogel, W. B., & Duncan, P. W. (2005) · Stroke · doi:10.1161/01.str.0000153065.39325.fd · Cited by 272
Houston Paramedic and Emergency Stroke Treatment and Outcomes Study (HoPSTO)
Wojner-Alexandrov, A. W., Alexandrov, A. V., Rodriguez, D., Persse, D., & Grotta, J. C. (2005) · Stroke · doi:10.1161/01.str.0000170700.45340.39 · Cited by 252
Metadata
- Authors
- Reed, S. D., Cramer, S. C., Blough, D. K., Meyer, K., & Jarvik, J. G.
- Venue
- Stroke
- Published
- 2001-08
- Volume
- 32
- Issue
- 8
- Pages
- 1832-1840
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W1928670726
- Cited by
- 255
- References
- 39
- FWCI
- 7.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.